InVivo Therapeutics Corporation' Frank Reynolds Named a "CFO of the Year" Finalist by Boston Business Journal

Published: Jun 05, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI) and other neurotrauma conditions, today announced that InVivo’s Chief Executive Officer and Chief Financial Officer Frank Reynolds has been named as a finalist in the fifth annual Boston Business Journal’s CFO of the Year Awards. Reynolds has been selected as a finalist in the Public Company category.

Help employers find you! Check out all the jobs and post your resume.

Back to news